Blood Research

Cited by CrossRef (44)

  1. Xiaosheng Li, Yue Chen, Anlong Sun, Ying Wang, Yao Liu, Haike Lei. Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China. BMC Med Inform Decis Mak 2023;23
    https://doi.org/10.1186/s12911-023-02198-0
  2. Ivan Dzis, Oleksandra Tomashevska, Yevhen Dzis, Zoryana Korytko. Prediction of survival in non-Hodgkin lymphoma based on markers of systemic inflammation, anemia, hypercoagulability, dyslipidemia, and Eastern Cooperative Oncology Group performance status. 2020;51:34
    https://doi.org/10.2478/ahp-2020-0008
  3. Jihoon Kang, Shinkyo Yoon, Cheolwon Suh. Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era. Blood Res 2017;52:276
    https://doi.org/10.5045/br.2017.52.4.276
  4. Ze Jin, Yi Miao, Jie Zhang, Jing Zhang, Chunling Wang, Xuzhang Lu, Yuqing Miao, Miao Sun, Yunping Zhang, Yun Zhuang, Haiwen Ni, Jingyan Xu, Wanchuan Zhuang, Min Zhao, Jianfeng Zhu, Min Xu, Guoqiang Lin, Haiying Hua, Xiaoyan Xie, Maozhong Xu, Tao Jia, Lijia Zhai, Weiying Gu, Qiurong Shan, Zhi Wang, Qiudan Shen, Xiaohui Zhang, Jianyong Li, Wenyu Shi. The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients. Ann Hematol 2024
    https://doi.org/10.1007/s00277-024-05631-0
  5. Changhoon Yoo, Dok Hyun Yoon, Shin Kim, Jooryung Huh, Chan-Sik Park, Chan-Jeong Park, Sang-Wook Lee, Cheolwon Suh. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematol Oncol 2016;34:22
    https://doi.org/10.1002/hon.2188
  6. Da-Yong Huang, Yi-Fei Hu, Na Wei, Li Fu, Lin Wu, Jing Shen, Jing-Shi Wang, Zhao Wang. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis. 2019;132:294
    https://doi.org/10.1097/CM9.0000000000000088
  7. Hyung‐Don Kim, Hyungwoo Cho, Hyehyun Jeong, Kyunghye Bang, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan‐Sik Park, Jooryung Huh, Jin‐Sook Ryu, Sang‐Wook Lee, Dok Hyun Yoon, Sung Yong Oh, Cheolwon Suh. A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels. Br J Haematol 2021;193:307
    https://doi.org/10.1111/bjh.17222
  8. Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Seyed H. Ghaffari, Davood Bashash. Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy. International Immunopharmacology 2022;103:108499
    https://doi.org/10.1016/j.intimp.2021.108499
  9. Tamseela Mumtaz, Muhammad Amir Iqbal, Nabila Roohi, Muhammad Waheed Akhtar. Increased Turnover of Beta 2 Microglobulin in Circulation serves as Diagnostic and Prognostic Marker for Malignant Lymphoma; A Case Control Predictive Model for Lymphoma Diagnosis. PJHS 2023:160
    https://doi.org/10.54393/pjhs.v4i05.757
  10. Theodoros P. Vassilakopoulos, Maria Arapaki, Panagiotis T. Diamantopoulos, Athanasios Liaskas, Fotios Panitsas, Marina P. Siakantaris, Maria Dimou, Styliani I. Kokoris, Sotirios Sachanas, Marina Belia, Chrysovalantou Chatzidimitriou, Elianna A. Konstantinou, John V. Asimakopoulos, Kyriaki Petevi, George Boutsikas, Alexandros Kanellopoulos, Alexia Piperidou, Maria-Ekaterini Lefaki, Angeliki Georgopoulou, Anastasia Kopsaftopoulou, Kalliopi Zerzi, Ioannis Drandakis, Maria N. Dimopoulou, Marie-Christine Kyrtsonis, Panayiotis Tsaftaridis, Eleni Plata, Eleni Variamis, Gerassimos Tsourouflis, Flora N. Kontopidou, Kostas Konstantopoulos, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Maria K. Angelopoulou. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients. Cancers 2024;16:238
    https://doi.org/10.3390/cancers16020238
  11. Javier I. Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, Ana Henriques, Esther Viñas, Carlos Prieto, Laura Sánchez-Muñoz, Carolina Caldas, Andrea Mayado, Almudena Matito, Noelia Dasilva-Freire, Alberto Orfao, Andrés C. García-Montero. Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis. 2019;134:456
    https://doi.org/10.1182/blood.2018886507
  12. Mahsa Khanlari, Jennifer R. Chapman. Follicular lymphoma: updates for pathologists. J Pathol Transl Med 2022;56:1
    https://doi.org/10.4132/jptm.2021.09.29
  13. Denis Miyashiro, José Antonio Sanches. Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1141108
  14. Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Wataru Yamamoto, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Kenji Matsumoto, Chizuko Hashimoto, Sachiya Takemura, Etsuko Yamazaki, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura, Yoshiaki Ishigatsubo. Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy. Leukemia Research 2015;39:1187
    https://doi.org/10.1016/j.leukres.2015.08.016
  15. Riwaj Bhagat, Asna Shahab, Yukesh Karki, Samip Budhathoki, Mikki Sapkota. Intravascular Lymphoma-Associated Stroke: A Systematic Review of Case Studies. 2023
    https://doi.org/10.7759/cureus.50896
  16. Mohleen Kang, Nitasha Bhatia, Adrienne Sauder, Mirela Feurdean. Angioimmunoblastic T Cell Lymphoma Mimicking Chronic Urticaria. Case Reports in Medicine 2016;2016:1
    https://doi.org/10.1155/2016/8753235
  17. Gaetano Romano. Tumor markers currently utilized in cancer care. MATER METHODS 2015;5
    https://doi.org/10.13070/mm.en.5.1456
  18. Sung Whan Cha, In Sik Shin, Deok Gie Kim, Sung Hoon Kim, Jun Young Lee, Jae Seok Kim, Jae Won Yang, Byoung-Geun Han, Seung Ok Choi. Effectiveness of serum beta-2 microglobulin as a tool for evaluating donor kidney status for transplantation. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-65134-6
  19. Taichi Omachi, Naho Atsumi, Takashi Yamazoe, Sohsaku Yamanouchi, Ryosuke Matsuno, Tomoki Kitawaki, Kazunari Kaneko. Differential Diagnosis of Histiocytic Necrotizing Lymphadenitis and Malignant Lymphoma with Simple Clinical Findings. Children 2022;9:290
    https://doi.org/10.3390/children9020290
  20. Sujit Kumar Verma, Anja Karin Albrecht, Verena Siebecke, Gerd Klöck, Tatiana A. Kolesnikova, Sebastian Springer, Christina Chan. Comparative validation of a microcapsule-based immunoassay for the detection of proteins and nucleic acids. PLoS ONE 2018;13:e0201009
    https://doi.org/10.1371/journal.pone.0201009
  21. Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. J Mol Med 2023;101:595
    https://doi.org/10.1007/s00109-023-02313-8
  22. Abdulkerim Yıldız, Murat Albayrak, Çiğdem Pala, Hacer B Afacan Öztürk, Senem Maral, Osman Şahin, Pınar Cömert. The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: A 9-year single-center experience. J Oncol Pharm Pract 2020;26:386
    https://doi.org/10.1177/1078155219851540
  23. Gilles Grangé, Marie Clémence Leguy, Vassilis Tsatsaris, Jean Guibourdenche. Biomarkers in Kidney Disease. 2020.
    https://doi.org/10.1007/978-94-007-7699-9_21
  24. Georgia Kaiafa, Mattheos Bobos, Christos Savopoulos, Theocharis Koutsokostas, Kostas Kouskouras, Anna Kalogera-Fountzila, Thomas Zaraboukas, Ioannis Kostopoulos, Vassilis Perifanis, Stavros Hadjimiltiades. RETRACTED: An Uncommon Case of Secondary Cardiac Lymphoma Manifested through Pre-Syncope, Syncope Episodes and Atrial Flutter. JCT 2016;07:986
    https://doi.org/10.4236/jct.2016.713096
  25. Ji‐Wei Li, Ya‐Jun Li, Mei‐Zuo Zhong, Xian‐Ling Liu, Jin Li, Kun‐Lun Li, Xi‐Yu Liu, Fang Zhou, Zhou OuYang, Zhong‐Yi Sun, Li‐Jun Huang, Jun‐Qiao He, Hui Zhou, Ping‐Yong Yi. Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study. European J of Haematology 2018;100:247
    https://doi.org/10.1111/ejh.13004
  26. Bayazid Ghaderi, Sabrieh Amini, Farzad Maroofi, Chiya Jalali, Mitra Javanmardi, Daem Roshani, Mohammad Abdi. Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects. Iran J Cancer Prev 2016;9
    https://doi.org/10.17795/ijcp-5069
  27. Christos P. Argyropoulos, Shan Shan Chen, Yue-Harn Ng, Maria-Eleni Roumelioti, Kamran Shaffi, Pooja P. Singh, Antonios H. Tzamaloukas. Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front. Med. 2017;4
    https://doi.org/10.3389/fmed.2017.00073
  28. Nadia Sarween, Mark T. Drayson, James Hodson, Ellen M. Knox, Timothy Plant, Clara J. Day, Graham W. Lipkin. Humoral immunity in late‐onset Pre‐eclampsia and linkage with angiogenic and inflammatory markers. American J Rep Immunol 2018;80
    https://doi.org/10.1111/aji.13041
  29. Cem Mirili, Semra Paydas, Tuba Korkmaz Kapukaya, Ali Yılmaz. Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomarkers in Medicine 2019;13:1565
    https://doi.org/10.2217/bmm-2019-0303
  30. Michael J. Boyer, Satoru Eguchi. Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis. 2018;132:2117
    https://doi.org/10.1042/CS20180681
  31. Ling Li, Mei Dong, Xiao-Guang Wang. The Implication and Significance of Beta 2 Microglobulin. 2016;129:448
    https://doi.org/10.4103/0366-6999.176084
  32. Tiantong Jiang, Xiurong Ding, Weixing Lu. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis. Disease Markers 2016;2016:1
    https://doi.org/10.1155/2016/1523959
  33. Samuel Lara-Reyna, James A. Poulter, Elton J.R. Vasconcelos, Mark Kacar, Michael F. McDermott, Reuben Tooze, Rainer Doffinger, Sinisa Savic. Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. J Clin Immunol 2021;41:441
    https://doi.org/10.1007/s10875-020-00932-1
  34. Alexandre Bertucci, Céline Boucard, Vincent Harlay, Romain Appay, Gregorio Petrirena, Maryline Barrié, Olivier Chinot, Emeline Tabouret. Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.. Journal of the Neurological Sciences 2024;457:122847
    https://doi.org/10.1016/j.jns.2023.122847
  35. Sora Kang, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Yoon Sei Lee, Chan-Sik Park, Heounjeong Go, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Seok Jin Kim, Won Seog Kim, Sang Eun Yoon, Young Hyeh Ko, Cheolwon Suh. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK. Cancer Res Treat 2023;55:314
    https://doi.org/10.4143/crt.2022.015
  36. Andrew Li, Limei Poon, Kay-Leong Khoo, Ju-Ee Seet, Arvind Kumar Sinha, Pyng Lee. A Man With Pleural Effusion and Ascites. Chest 2015;147:e208
    https://doi.org/10.1378/chest.14-2237
  37. Ning-Chun Chen, Hung Chang, Hsiao-Wen Kao, Che-Wei Ou, Ming-Chung Kuo, Po-Nan Wang, Tung-Liang Lin, Jin-Hou Wu, Yu-Shin Hung, Yi-Jiun Su, Yuen-Chin Ong, Hsuan-Jen Shih. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clin Exp Med 2023;23:3759
    https://doi.org/10.1007/s10238-023-01061-w
  38. Jae‐Hyeon Im, Su‐Min Park, Ju‐Hyun An, Tea‐Hee Kim, Hyung‐Kyu Chae, Ye‐In Oh, Kyoung‐Won Seo, Hwa‐Young Youn. Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study. Vet Comparative Oncology 2023;21:184
    https://doi.org/10.1111/vco.12873
  39. Sujit K. Verma, Amanda Amoah, Ulla Schellhaas, Mathias Winterhalter, Sebastian Springer, Tatiana A. Kolesnikova. “To Catch or Not to Catch”: Microcapsule‐Based Sandwich Assay for Detection of Proteins and Nucleic Acids. Adv Funct Materials 2016;26:6015
    https://doi.org/10.1002/adfm.201601328
  40. Daniel Silva Nogueira, Luís Alberto de Pádua Covas Lage, Hebert Fabrício Culler, Juliana Pereira. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes. Clinical Lymphoma Myeloma and Leukemia 2022;22:67
    https://doi.org/10.1016/j.clml.2021.08.004
  41. Hunter B. Moore, Ernest E. Moore, Alexander P. Morton, Eduardo Gonzalez, Miguel Fragoso, Michael P. Chapman, Monika Dzieciatkowska, Kirk C. Hansen, Anirban Banerjee, Angela Sauaia, Christopher C. Silliman. Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. 2015;79:897
    https://doi.org/10.1097/TA.0000000000000792
  42. Manal Mohamed Makhlouf, Eman Roshdy Radwan, Ola Mohamed Khorshed, Lamees Mohamed Fathi, Manal Mohamed Elmasry. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma. Pathobiology 2021;88:211
    https://doi.org/10.1159/000510456
  43. Gilles Grangé, Marie Clémence Leguy, Vassilis Tsatsaris, Jean Guibourdenche. Biomarkers in Kidney Disease. 2021.
    https://doi.org/10.1007/978-94-007-7743-9_21-1
  44. Ingrid Ruiz-Ordoñez, Juan-Manuel Piedrahita, Javier-Andrés Arévalo, Andrés Agualimpia, Gabriel J. Tobón. Lymphomagenesis predictors and related pathogenesis. Journal of Translational Autoimmunity 2021;4:100098
    https://doi.org/10.1016/j.jtauto.2021.100098
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd